English
Back
Download
Log in to access Online Inquiry
Back to the Top

$CERo Therapeutics (CERO.US)$ CERo Therapeutics (CERO) share...

$CERo Therapeutics (CERO.US)$ CERo Therapeutics (CERO) shares surged 62%. The US Food and Drug Administration cleared the company's investigational new drug application for a phase 1 trial of its lead compound CER-1236 to treat acute myelogenous leukemia.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
7969 Views
Comment
Sign in to post a comment
    236
    Followers
    8
    Following
    1582
    Visitors
    Follow

    Market Insights

    Market Hot Picks Market Hot Picks
    Unlock Now

    Reassessing Chinese Assets

    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.